Seeking Alpha
 

Enzon Pharmaceuticals, Inc. (ENZN)

- NASDAQ
  • Mar. 19, 2013, 6:39 AM
    Enzon Pharmaceuticals (ENZN): Q4 EPS of -$0.11. Revenue of $10.6M. (PR)
    | Comment!
Visit Seeking Alpha's
ENZN vs. ETF Alternatives
Company Description
Enzon Pharmaceuticals Inc is related to sales of drugs by various companies.
Sector: Healthcare
Industry: Biotechnology
Country: United States